Publication:
Receipt of Statins Is Associated With Lower Risk of Multiple Myeloma: Systematic Review and Meta-analysis

Issued Date

2020-01-01

Resource Type

Article

ISSN

21522669
21522650

DOI

10.1016/j.clml.2020.02.011

Other identifier(s)

2-s2.0-85081952857

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Clinical Lymphoma, Myeloma and Leukemia. (2020)

Suggested Citation

Ben Ponvilawan, Nipith Charoenngam, Thanitsara Rittiphairoj, Patompong Ungprasert Receipt of Statins Is Associated With Lower Risk of Multiple Myeloma: Systematic Review and Meta-analysis. Clinical Lymphoma, Myeloma and Leukemia. (2020). doi:10.1016/j.clml.2020.02.011 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54484

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Receipt of Statins Is Associated With Lower Risk of Multiple Myeloma: Systematic Review and Meta-analysis

Author(s)

Ben Ponvilawan
 Nipith Charoenngam
 Thanitsara Rittiphairoj
 Patompong Ungprasert

Other Contributor(s)

Faculty of Medicine, Siriraj Hospital, Mahidol University
 Johns Hopkins Bloomberg School of Public Health

Abstract

© 2020 Elsevier Inc. Data on receipt of statins and risk of multiple myeloma (MM) are still conflicting. We performed a systematic review that comprised terms for “statin” and “multiple myeloma” and identified 10 eligible studies for meta-analysis. The risk of MM was significantly lower among statin recipients than those who did not receive statins.

Keyword(s)

Biochemistry, Genetics and Molecular Biology
 Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/54484

Collections

Scopus 2020